Dr Robert I. Field joins Ethics Talk to discuss whether and to what extent private equity firms’ increasing presence in health care deserves our scrutiny and what policy makers, clinicians, and patients should know about responding to private equity ownership stakes in the organizations where they work and where they go for health services.

Risk-benefit analyses are part of most health decisions and are investigated visually and narratively in this comic.

Lio Barnhardt joins Ethics Talk to discuss their comic: “Decision Tree Comic.”

The first cells of this multi-panel comic represent the artist’s personal experiences of testing positive for and enduring COVID-19 in January 2024.

Teddie Bernard joins Ethics Talk to discuss their comic: A Comic About COVID-19 in 2024.

Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions.

Dr Kevin Schulman joins Ethics Talk to discuss his article, coauthored with Dr Barak Richman: “Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm.”

Fragmentation in US health care delivery streams and shortcomings in formal quality measures mean that transparency could be more useful to policymakers and regulators than patients.

Dr Christopher Whaley joins Ethics Talk to discuss his article, coauthored with Dr Austin Frakt: “If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important?”

Dr Jing Li joins Ethics Talk to discuss her article, coauthored with Dr Robert Tyler Braun, Sophia Kakarala, and Dr Holly G. Prigerson: “How Should Cost-Informed Goals of Care Decisions Be Facilitated at Life’s End?”